MAPT and Alzheimer disease: In mice, for example, impaired cell signaling was found to be closely associated with cognitive impairment [21], while, in the human brain, Meakin et al. identified impaired glucose metabolism as an early feature of AD that is directly related to tau and Aβ metabolism, making diabetes a distinct risk factor for the clinical onset of AD [7].